PURE Financial Facts

Cost of goods sold: 20K
Loss from operations: -3.22M
See Full Income Statement

Accumulated deficit: -76.5M
Patents, net: 1.4M
See Full Balance Sheet

Pure Bioscience (PURE) Earnings

  |   Expand Research on PURE
Next EPS Date 9/9/14 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate N/A Revenue Growth Rate N/A
Average % Move 1-Wk after EPS N/A Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
6/10/14 Q314 -$0.07N/A N/A $261K$258K N/A Details
12/12/12 Q113 -$0.25N/A N/A $110K$257K N/A Details
6/13/12 Q312 -$0.04N/A N/A $207K$128M N/A Details
3/16/12 Q212 -$0.05N/A N/A $221K$68K N/A Details
12/15/11 Q112 -$0.06N/A N/A $257K$23K N/A Details
10/31/11 Q411 -$0.05N/A N/A $244K$324K N/A Details
6/13/11 Q311 -$0.05N/A N/A $128.4K$536.5K N/A Details
3/17/11 Q211 -$0.07N/A N/A N/A$3.22B N/A Details